AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Owkin and AstraZeneca Expand Their AI Research Partnership as Pharma Bets on Smarter Discovery
Owkin and AstraZeneca are expanding collaboration on AI-driven drug research tools, adding another example of big pharma leaning into AI partnerships rather than trying to build everything in-house. The move suggests the market is maturing toward a hybrid model of internal science and external AI capabilities.
Isomorphic Labs’ Human Trials Mark the First Real Test of AI-Designed Drugs
Isomorphic Labs is reportedly sending AI-designed medicines into human trials, a milestone that could move the drug discovery debate from theoretical promise to clinical proof. The real question now is not whether AI can generate candidates faster, but whether it can consistently produce safer, more effective drugs than conventional approaches.
Big Tech’s Drug Discovery Push Is Turning AI Into a Life Sciences Platform War
Axios reports that Big Tech is circling drug discovery, reinforcing the idea that life sciences is becoming a strategic battleground for AI platforms. As major technology companies move closer to pharma, the competition is shifting from standalone tools to end-to-end ecosystems that can own the scientific workflow.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.